Bioventus Inc.
BVS · NASDAQ
9/27/2025 | 6/28/2025 | 3/29/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $42 | $33 | $23 | $42 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $130 | $132 | $118 | $127 |
| Inventory | $96 | $96 | $94 | $92 |
| Other Curr. Assets | $12 | $13 | $14 | $14 |
| Total Curr. Assets | $281 | $275 | $249 | $276 |
| Property Plant & Equip (Net) | $29 | $31 | $32 | $34 |
| Goodwill | $7 | $7 | $7 | $7 |
| Intangibles | $377 | $387 | $396 | $405 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $5 | $5 | $5 | $5 |
| Other NC Assets | $2 | $2 | $2 | $2 |
| Total NC Assets | $421 | $432 | $442 | $452 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $702 | $707 | $691 | $728 |
| Liabilities | – | – | – | – |
| Payables | $27 | $24 | $19 | $24 |
| Short-Term Debt | $11 | $43 | $37 | $27 |
| Tax Payable | $0 | $5 | $6 | $4 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $124 | $113 | $112 | $156 |
| Total Curr. Liab. | $162 | $186 | $175 | $210 |
| LT Debt | $311 | $298 | $309 | $308 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $1 | $1 | $1 | $1 |
| Other NC Liab. | $20 | $21 | $22 | $23 |
| Total NC Liab. | $333 | $320 | $331 | $332 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $494 | $505 | $506 | $542 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$350 | -$353 | -$360 | -$355 |
| AOCI | -$2 | -$1 | -$2 | -$3 |
| Other Equity | $518 | $515 | $510 | $506 |
| Total Equity | $166 | $161 | $148 | $148 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $41 | $40 | $37 | $38 |
| Total Liab. & Tot. Equity | $702 | $707 | $691 | $728 |
| Net Debt | $280 | $308 | $323 | $294 |